Stock Research for ANIP

ANIP
Current Price

$56.9600


Latest Update: 2018-02-23 16:00:00

High
$ 56.9900
Low
$ 56.8300
Close
$ 56.9800
Volume
12790
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ANIP Stock Chart & Research Data

The ANIP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ANIP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ANIP Due diligence Resources & Stock Charts

The ANIP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ANIP Detailed Price Forecast - CNN Money CNN View ANIP Detailed Summary - Google Finance
Yahoo View ANIP Detailed Summary - Yahoo! Finance Zacks View ANIP Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ANIP Trends & Analysis - Trade-Ideas Barrons View ANIP Major Holders - Barrons
NASDAQ View ANIP Call Transcripts - NASDAQ Seeking View ANIP Breaking News & Analysis - Seeking Alpha
Spotlight View ANIP Annual Report - CompanySpotlight.com OTC Report View ANIP OTC Short Report - OTCShortReport.com
TradeKing View ANIP Fundamentals - TradeKing Charts View ANIP SEC Filings - Bar Chart
WSJ View Historical Prices for ANIP - The WSJ Morningstar View Performance/Total Return for ANIP - Morningstar
MarketWatch View the Analyst Estimates for ANIP - MarketWatch CNBC View the Earnings History for ANIP - CNBC
StockMarketWatch View the ANIP Earnings - StockMarketWatch MacroAxis View ANIP Buy or Sell Recommendations - MacroAxis
Bullish View the ANIP Bullish Patterns - American Bulls Short Pains View ANIP Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ANIP Stock Mentions - StockTwits PennyStocks View ANIP Stock Mentions - PennyStockTweets
Twitter View ANIP Stock Mentions - Twitter Invest Hub View ANIP Investment Forum News - Investor Hub
Yahoo View ANIP Stock Mentions - Yahoo! Message Board Seeking Alpha View ANIP Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ANIP - SECform4.com Insider Cow View Insider Transactions for ANIP - Insider Cow
CNBC View ANIP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ANIP - OTC Markets
Yahoo View Insider Transactions for ANIP - Yahoo! Finance NASDAQ View Institutional Holdings for ANIP - NASDAQ


Stock Charts

FinViz View ANIP Stock Insight & Charts - FinViz.com StockCharts View ANIP Investment Charts - StockCharts.com
BarChart View ANIP Stock Overview & Charts - BarChart Trading View View ANIP User Generated Charts - Trading View


Latest Financial News for ANIP

ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results and 2018 Guidance
Posted on Tuesday February 20, 2018

BAUDETTE, Minn. , Feb. 20, 2018 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and 2018 ...


Investors Are Undervaluing ANI Pharmaceuticals Inc (NASDAQ:ANIP) By 39.62%, Here Is My Intrinsic Value Calculation
Posted on Tuesday February 13, 2018

Today I will be providing a simple run-through of the discounted cash flows (DCF) method to estimate the attractiveness of ANI Pharmaceuticals Inc (NASDAQ:ANIP) as an investment opportunity. If youRead More...


Top-Rated Stocks: ANI Pharmaceuticals Sees Composite Rating Climb To 97
Posted on Wednesday January 03, 2018

ANI Pharmaceuticals saw its IBD SmartSelect Composite Rating rise to 97 Wednesday, up from 94 the day before.


ANI Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ANIP-US : January 1, 2018
Posted on Monday January 01, 2018

Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ANI Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)


ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and ...
PR Newswire (press release) - Feb 20, 2018
ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals ...

ANI Pharmaceuticals Inc. (ANIP) Moves Lower on Volume Spike for February 22
Equities.com - Feb 22, 2018
ANI Pharmaceuticals Inc. (ANIP) traded on unusually high volume on Feb. 22, as the stock lost 0.52% to close at $57.64. On the day, ANI Pharmaceuticals Inc. saw 188,528 shares trade hands on 1,592 trades. Considering that the stock averages only a ...
ANI Pharmaceuticals, Inc. (ANIP) Analysts See $1.02 EPS - BZ Weekly
$1.02 EPS Expected for ANI Pharmaceuticals, Inc. (ANIP) - Frisco Fastball

Ani Pharmaceuticals: Potential Buyout Gains Credence
Seeking Alpha - Nov 20, 2017
The merger with Ani Pharmaceuticals (NASDAQ:ANIP) and the subsequent reverse split left Biosante Pharmaceuticals shareholders with approximately 4,125,800 shares of Ani Pharmaceuticals (43% of the merged company) in June 2013. How much would a Biosante ...

ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million
PR Newswire (press release) - Dec 29, 2017
BAUDETTE, Minn., Dec. 29, 2017 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has acquired the NDAs and U.S.
ANI Pharmaceuticals acquires four AstraZeneca NDAs - Seeking Alpha

Enter a stock symbol to view the stock details.